MarginsXMarginsX
Home › Markets › BDPT

Bioadaptives, Inc. (BDPT)

BDPT is quoted over the counter, not listed on an exchange. Bioadaptives, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.0013
+4.2% on the day
1-year return
-97.1%
Market cap
$246K
Nano cap. From the Nov 13, 2026 close × 196.9M shares (10-Q cover page, Aug 13, 2026)
P/E and P/S
Net loss over the period · 9.6×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerBDPT, quoted over the counter
SEC CIK0001575142
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressLas Vegas, NV
Incorporated inDE

Warning signs

Cash runway
0.8 months
$29K cash at June 30, 2026
Share count, 1 year
+1879.4%
2025-08-15 to 2026-08-13 · +3704.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The ability to successfully resolve these factors raises substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-08-19
Cash and burn$29K cash; operating cash flow -$109K a quarter.Report 2026-06-30
Shares outstanding196,926,762 (2026-08-13); 9,948,659 a year earlier; 776,464,023 three years earlier. 3y figure adjusted for splits (1-for-150 overall).Cover page 2026-08-13
Reverse splits, 3 years1; latest 1-for-300 on 2024-11-21Source 2024-11-21
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBoladale Lawal & Co ( Chartered Accountants), Lagos, NigeriaPCAOB Form AP 2026-04-19
Late filings, 12 months2 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$5K$150K-$44K$29K$1.0M$26K10-Q 2026-08-19
Q1 2026
2026-03-31
$6K-$111K-$85K$74K$881K$24K10-Q 2026-05-15
Q4 2025
2025-12-31
$10K-$823K-$156K$215K$737K$18K10-K 2026-04-14
Q3 2025
2025-09-30
$5K-$380K-$151K$59K$391K$8K10-Q 2025-11-14
Q2 2025
2025-06-30
$3K-$158K-$111K$211K$343K$3K10-Q 2026-08-19
Q1 2025
2025-03-31
$0-$197K-$98K$40K$343K$67510-Q 2026-05-15
Q4 2024
2024-12-31
$0-$372K-$101K$262K$954K$13K10-K 2026-04-14
Q3 2024
2024-09-30
$0-$38K-$56K$44K$343K$20K10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document1-A2023-10-11
Latest annual report10-K2026-04-14
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-04

Source: SEC EDGAR submissions feed, 177 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier